244 related articles for article (PubMed ID: 16970675)
1. Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses.
Pahuja A; Maki RA; Hevezi PA; Chen A; Verge GM; Lechner SM; Roth RB; Zlotnik A; Alleva DG
Scand J Immunol; 2006 Oct; 64(4):361-9. PubMed ID: 16970675
[TBL] [Abstract][Full Text] [Related]
2. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
3. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
Schneider MA; Meingassner JG; Lipp M; Moore HD; Rot A
J Exp Med; 2007 Apr; 204(4):735-45. PubMed ID: 17371928
[TBL] [Abstract][Full Text] [Related]
4. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
[TBL] [Abstract][Full Text] [Related]
5. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes.
Saeki H; Moore AM; Brown MJ; Hwang ST
J Immunol; 1999 Mar; 162(5):2472-5. PubMed ID: 10072485
[TBL] [Abstract][Full Text] [Related]
7. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
[TBL] [Abstract][Full Text] [Related]
8. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.
Kellermann SA; Hudak S; Oldham ER; Liu YJ; McEvoy LM
J Immunol; 1999 Apr; 162(7):3859-64. PubMed ID: 10201903
[TBL] [Abstract][Full Text] [Related]
9. CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.
Ueha S; Yoneyama H; Hontsu S; Kurachi M; Kitabatake M; Abe J; Yoshie O; Shibayama S; Sugiyama T; Matsushima K
J Leukoc Biol; 2007 Nov; 82(5):1230-8. PubMed ID: 17698914
[TBL] [Abstract][Full Text] [Related]
10. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
Ebert LM; Schaerli P; Moser B
Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
[TBL] [Abstract][Full Text] [Related]
11. Generalized multi-organ autoimmunity in CCR7-deficient mice.
Davalos-Misslitz AC; Rieckenberg J; Willenzon S; Worbs T; Kremmer E; Bernhardt G; Förster R
Eur J Immunol; 2007 Mar; 37(3):613-22. PubMed ID: 17304629
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
Okada N; Mori N; Koretomo R; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
Gene Ther; 2005 Jan; 12(2):129-39. PubMed ID: 15483669
[TBL] [Abstract][Full Text] [Related]
13. CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance.
Kurobe H; Liu C; Ueno T; Saito F; Ohigashi I; Seach N; Arakaki R; Hayashi Y; Kitagawa T; Lipp M; Boyd RL; Takahama Y
Immunity; 2006 Feb; 24(2):165-77. PubMed ID: 16473829
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.
Liston A; Kohler RE; Townley S; Haylock-Jacobs S; Comerford I; Caon AC; Webster J; Harrison JM; Swann J; Clark-Lewis I; Korner H; McColl SR
J Immunol; 2009 Mar; 182(5):3121-30. PubMed ID: 19234209
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis.
Liu L; Graham GJ; Damodaran A; Hu T; Lira SA; Sasse M; Canasto-Chibuque C; Cook DN; Ransohoff RM
J Immunol; 2006 Jul; 177(1):17-21. PubMed ID: 16785491
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue.
Kocks JR; Davalos-Misslitz AC; Hintzen G; Ohl L; Förster R
J Exp Med; 2007 Apr; 204(4):723-34. PubMed ID: 17371929
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
Alt C; Laschinger M; Engelhardt B
Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
[TBL] [Abstract][Full Text] [Related]
18. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells.
Schumann K; Lämmermann T; Bruckner M; Legler DF; Polleux J; Spatz JP; Schuler G; Förster R; Lutz MB; Sorokin L; Sixt M
Immunity; 2010 May; 32(5):703-13. PubMed ID: 20471289
[TBL] [Abstract][Full Text] [Related]
19. CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming.
Martín-Fontecha A; Baumjohann D; Guarda G; Reboldi A; Hons M; Lanzavecchia A; Sallusto F
J Exp Med; 2008 Oct; 205(11):2561-74. PubMed ID: 18838544
[TBL] [Abstract][Full Text] [Related]
20. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis.
Hartigan AJ; Westwick J; Jarai G; Hogaboam CM
J Immunol; 2009 Oct; 183(8):5171-9. PubMed ID: 19783686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
